Skip to main content Skip to main navigation menu Skip to site footer

Research map in the field of psychoneuroimmunology therapy, a bibliometric analysis



Abstract

Introduction: Psychoneuroimmunology is an exciting field to study because of its essential role in a person's life quality. Therapy in psychoneuroimmunology is multidisciplinary to treat stress, insomnia, depression, schizophrenia, infections, neoplasms, autoimmune, metabolic, and cognitive disorders. Treatment has been used in the form of Tai-chi, Qi-gong, C.B.T., mindfulness meditation, hypnosis, and others, with therapeutic results that have not yet reached the optimal, so there seems to be much effort to find new therapies with more satisfying results. Until now, as far as we know, no bibliometric study has been related to treatment in the field of psychoneuroimmunology. So, this bibliometric analysis is aimed at conducting quantitative and qualitative analysis to get a more detailed picture of the study related to treatment in the field of psychoneuroimmunology.

Methods: Documents were collected from Scopus from 1946 to 2022. Furthermore, data purification was carried out. Using the Biblioshiny and VOSviewer applications, data are obtained, which are then analyzed quantitatively and qualitatively.

Results: Obtained data related to the author, the number of citations, journals containing research related to psychoneuroimmunology therapy, clusters based on keywords, and future research trend (spirituality therapy).

Conclusion: A detailed description of aspects of neuropsychological therapy has been obtained in the form of areas that have been widely studied, which are still under-researched, as well as new therapeutic trends for the future in the form of an emerging area (niche) in psychoneuroimmunology therapy, namely spirituality therapy.

Keywords: bibliometric therapy psychoneuroimmunology trend research spirituality

References

  1. Coates TJ, Temoshok L, Mandel J. Psychosocial research is essential to understanding and treating AIDS. Vol. 39, American Psychologist. US: American Psychological Association; 1984. p. 1309–14.
  2. Tresker S. Consciousness, Placebo Effects, and the Therapeutic Allure of Psychoneuroimmunology. Perspectives in Biology and Medicine. 2022; 65(1-24). Available from: 10.1353/pbm.2022.0000.
  3. Antoni MA-O, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer. 2019; (1097-0142). Available from: https://doi.org/10.1002/cncr.31943.
  4. Chacin-Fernández J, Chacin Fuenmayor M, Piñerua-Shuhaibar L, Suarez-Roca H. Psychological intervention based on psychoneuroimmunology improves clinical evolution, quality of life, and immunity of children with leukemia: A preliminary study. Health Psychology Open. 2019; (2055-1029). Available from: https://doi.org/10.1177%2F2055102919838902.
  5. Marshall GD, Tull MA-OX. Stress, mindfulness, and the allergic patient. Expert Review of Clinical Immunology. 2018; (1744-8409). Available from: https://doi.org/10.1080/1744666x.2018.1536547.
  6. Straub RH, Cutolo M. Psychoneuroimmunology—developments in stress research. Wiener Medizinische Wochenschrift. 2018 2018/03/01; 168(3):[76-84 pp.]. Available from: https://doi.org/10.1007/s10354-017-0574-2.
  7. Lissoni P, Messina G, Lissoni A, Franco R. The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results. Journal of Research in Medical Sciences. 2017; (1735-1995). Available from: https://doi.org/10.4103/jrms.jrms_255_16.
  8. Subnis UB, Starkweather Ar Fau - McCain NL, McCain Nl Fau - Brown RF, Brown RF. Psychosocial therapies for patients with cancer: a current review of interventions using psychoneuroimmunology-based outcome measures. Integrative Cancer Therapies. 2014; (1552-695X). Available from: https://doi.org/10.1177/1534735413503548.
  9. Heesen C, Köpke S Fau - Kasper J, Kasper J Fau - Poettgen J, Poettgen J Fau - Tallner A, Tallner A Fau - Mohr DC, Mohr Dc Fau - Gold SM, et al. Behavioral interventions in multiple sclerosis: a biopsychosocial perspective. Expert Review of Neurotherapeutics. 2012; (1744-8360). Available from: https://doi.org/10.1586/ern.12.103.
  10. Bedford FL. A perception theory in mind-body medicine: guided imagery and mindful meditation as cross-modal adaptation. Psychonomic Bulletin and Review. 2012; (1531-5320). Available from: https://doi.org/10.3758/s13423-011-0166-x.
  11. Khaikin AV. To The Theory And Practice Of Psychosomatics. Russian Open Medical Journal. 2012.
  12. SeyedAlinaghi S, Jam S Fau - Foroughi M, Foroughi M Fau - Imani A, Imani A Fau - Mohraz M, Mohraz M Fau - Djavid GE, Djavid Ge Fau - Black DS, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4⁺ T lymphocyte count and medical and psychological symptoms. Psychosomatic Medicine. 2012; (1534-7796). Available from: https://doi.org/10.1097/psy.0b013e31825abfaa.
  13. Maes M, Twisk F. Chronic Fatigue Syndrome: la bete noire of the Belgian Health Care System. Neuro endocrinology letters. 2009 08/01; 30:[300-11 pp.].
  14. Cuellar NG. Mindfulness meditation for veterans---implications for occupational health providers. AAOHN journal : official journal of the American Association of Occupational Health Nurses. 2008; (0891-0162).
  15. Witek-Janusek L, Albuquerque K Fau - Chroniak KR, Chroniak Kr Fau - Chroniak C, Chroniak C Fau - Durazo-Arvizu R, Durazo-Arvizu R Fau - Mathews HL, Mathews HL. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain, Behavior, and Immunity. 2008; (1090-2139). Available from: https://doi.org/10.1016/j.bbi.2008.01.012.
  16. Goebel M, Meykadeh N, Kou W, Schedlowski M, Hengge U. Behavioral Conditioning of Antihistamine Effects in Patients with Allergic Rhinitis. Psychotherapy and psychosomatics. 2008 02/01; 77:[227-34 pp.]. Available from: http://dx.doi.org/10.1159/000126074.
  17. Carrico A, Antoni M. Effects of Psychological Interventions on Neuroendocrine Hormone Regulation and Immune Status in HIV-Positive Persons: A Review of Randomized Controlled Trials. Psychosomatic medicine. 2008 07/01; 70:[575-84 pp.]. Available from: http://dx.doi.org/10.1097/PSY.0b013e31817a5d30.
  18. Andersen B, Farrar W, Golden-Kreutz D, Emery C, Glaser R, Crespin T, et al. Distress Reduction from a Psychological Intervention Contributes to Improved Health for Cancer Patients. Brain, behavior, and immunity. 2007 10/01; 21:[953-61 pp.]. Available from: http://dx.doi.org/10.1016/j.bbi.2007.03.005.
  19. Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C. The Effects of Psychological Intervention on Atopic Dermatitis. International archives of allergy and immunology. 2007 08/01; 144:[1-9 pp.]. Available from: http://dx.doi.org/10.1159/000101940.
  20. Berk L. Studying the biology of hope: An interview with Lee S. Berk, DrPH, MPH. Interview by Sheldon Lewis. Advances in mind-body medicine. 2007 06/01; 22:[28-31 pp.].
  21. Vedhara K, Bennett P, Clark S, Lightman S, Phillips S, Perks P, et al. Enhancement of Antibody Responses to Influenza Vaccination in the Elderly following a Cognitive-Behavioural Stress Management Intervention. Psychotherapy and psychosomatics. 2003 08/01; 72:[245-52 pp.]. Available from: http://dx.doi.org/10.1159/000071895.
  22. Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model. Stress and Health. 2003; (1025-3890). Available from: https://doi.org/10.1080/1025389031000156727.
  23. Jozuka H, Jozuka E Fau - Suzuki M, Suzuki M Fau - Takeuchi S, Takeuchi S Fau - Takatsu Y, Takatsu Y. Psycho-neuro-immunological treatment of hepatocellular carcinoma with major depression--a single case report. Current Medical Research and Opinion. 2003; (0300-7995). Available from: https://doi.org/10.1185/030079902125001362.
  24. Kiecolt-Glaser J, McGuire L, Robles T, Glaser R. Psychoneuroimmunology: Psychological influences on immune function and health. Journal of consulting and clinical psychology. 2002 07/01; 70:[537-47 pp.]. Available from: http://dx.doi.org/10.1037//0022-006X.70.3.537.
  25. Money M. Shamanism as a healing paradigm for complementary therapy. Complementary Therapies in Nursing and Midwifery. 2001; (1353-6117). Available from: https://doi.org/10.1054/ctnm.2001.0546.
  26. Robinson FP, Mathews HL, Witek-Janusek L. Stress Reduction and HIV Disease: A Review of Intervention Studies Using a Psychoneuroimmunology Framework. Journal of the Association of Nurses in AIDS Care. 2000 2000/03/01/; 11(2):[87-96 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/S1055329006602896.
  27. Eller LS. Effects of cognitive-behavioral interventions on quality of life in persons with HIV. International Journal of Nursing Studies. 1999 1999/06/01/; 36(3):[223-33 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/S0020748999000188.
  28. Coker KH. Meditation and prostate cancer: integrating a mind/body intervention with traditional therapies. Seminars in Urologic Oncology. 1999; (1081-0943).
  29. Caudell KA. Psychoneuroimmunology and innovative behavioral interventions in patients with leukemia. Oncology nursing forum. 1996; (0190-535X).
  30. Lindberg NE, Lindberg E Fau - Theorell T, Theorell T Fau - Larsson G, Larsson G. Psychotherapy in rheumatoid arthritis--a parallel-process study of psychic state and course of rheumatic disease. Zeitschrift fur Rheumatologie. 1996; (0340-1855).
  31. Benor R. Autogenic training. Complementary therapies in nursing & midwifery. 1996.
  32. Taylor DN. Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV positive men. Psychological reports. 1995; (0033-2941). Available from: https://doi.org/10.2466/pr0.1995.76.2.451.
  33. Mulder C, Antoni M, Emmelkamp P, Garssen B, Veugelers P, Sandfort T, et al. Psychosocial Group Intervention and the Rate of Decline of Immunological Parameters in Asymptomatic HIV-lnfected Homosexual Men. Psychotherapy and Psychosomatics. 1995 02/01; 63:[185-92 pp.]. Available from: http://dx.doi.org/10.1159/000288958.
  34. Mulder CL. Psychosocial correlates and the effects of behavioral interventions on the course of human immunodeficiency virus infection in homosexual men. Patient Education and Counseling. 1994 1994/12/01/; 24(3):[237-47 pp.]. Available from: https://www.sciencedirect.com/science/article/pii/0738399194900671.
  35. Gruber BL, Hersh Sp Fau - Hall NR, Hall Nr Fau - Waletzky LR, Waletzky Lr Fau - Kunz JF, Kunz Jf Fau - Carpenter JK, Carpenter Jk Fau - Kverno KS, et al. Immunological responses of breast cancer patients to behavioral interventions. Biofeedback and Self- Regulation. 1993; (0363-3586). Available from: https://doi.org/10.1007/bf00999510.
  36. Cottraux J. Behavioral Psychotherapy Applications in the Medically. Psychotherapy and psychosomatics. 1993 02/01; 60:[116-28 pp.]. Available from: http://dx.doi.org/10.1159/000288687.
  37. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology: can psychological interventions modulate immunity? Journal of Consulting and Clinical Psychology. 1992; (0022-006X). Available from: https://doi.org/10.1037//0022-006x.60.4.569.
  38. Teshima H, Sogawa H Fau - Nakagawa T, Nakagawa T Fau - Ago Y, Ago Y. Effects of the biopsychosocial approach (BPSA) on exercise-induced asthma (EIA). Fukuoka igaku zasshi Hukuoka acta medica. 1992; (0016-254X).
  39. Halley FM. Self-regulation of the immune system through biobehavioral strategies. Biofeedback and Self-Regulation. 1991; (0363-3586). Available from: https://doi.org/10.1007/bf01000446.
  40. Teshima H, Irie M Fau - Sogawa H, Sogawa H Fau - Nakagawa T, Nakagawa T Fau - Ago Y, Ago Y. Long-term follow-up investigation of the effects of the biopsychosocial approach (BPSA) to bronchial asthma. Fukuoka igaku zasshi Hukuoka acta medica. 1991; (0016-254X).
  41. Warner L, McNeill ME. Mental imagery and its potential for physical therapy. Physical Therapy. 1988; (0031-9023). Available from: https://doi.org/10.1093/ptj/68.4.516.
  42. Arefnasab Z, Babamahmoodi A, Babamahmoodi F, Noorbala AA, Alipour A, Panahi Y, et al. Mindfulness-based Stress Reduction (MBSR) and Its Effects on Psychoimmunological Factors of Chemically Pulmonary Injured Veterans. Iranian Journal of Allergy, Asthma and Immunology. 2016; (1735-1502).
  43. Barrera I, Spiegel D. Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. International Review of Psychiatry. 2014; (1369-1627). Available from: https://doi.org/10.3109/09540261.2013.864259.
  44. Bauer-Wu S. Psychoneuroimmunology Part II: Mind-Body Interventions. Clinical journal of oncology nursing. 2002 07/01; 6:[243-6 pp.]. Available from: http://dx.doi.org/10.1188/02.CJON.243-246.
  45. Murray K. EMDR Resource Methods for Women With Breast Cancer. Journal of EMDR Practice and Research. 2016 08/01; 10:[176-88 pp.]. Available from: https://doi.org/10.1891/1933-3196.10.3.176.
  46. Virago MC. Art psychotherapy and public health. Public Health. 2021 2021/07/01/; 196:[150-7 pp.]. Available from: https://doi.org/10.1016/j.puhe.2021.05.020.
  47. Fancourt D, Ockelford A, Belai A. The psychoneuroimmunological effects of music: a systematic review and a new model. Brain, Behavior, and Immunity. 2014; (1090-2139). Available from: https://doi.org/10.1016/j.bbi.2013.10.014.
  48. Lai HL, Liao Kw Fau - Huang C-Y, Huang Cy Fau - Chen P-W, Chen Pw Fau - Peng T-C, Peng TC. Effects of music on immunity and physiological responses in healthcare workers: a randomized controlled trial. Stress and Health. 2013; (1532-2998). Available from: https://doi.org/10.1002/smi.2429.
  49. Kimata H. Listening to Mozart Reduces Allergic Skin Wheal Responses and In Vitro Allergen-specific IgE Production in Atopic Dermatitis Patients with Latex Allergy. Behavioral medicine (Washington, DC). 2003 02/01; 29:[15-9 pp.]. Available from: http://dx.doi.org/10.1080/08964280309596170.
  50. Hanna J. The Power of Dance: Health and Healing. Journal of alternative and complementary medicine (New York, NY). 1995 02/01; 1:[323-31 pp.]. Available from: http://dx.doi.org/10.1089/acm.1995.1.323.
  51. Finn S, Fancourt D. The biological impact of listening to music in clinical and nonclinical settings: A systematic review. Progress in Brain Research. 2018; (1875-7855). Available from: https://doi.org/10.1016/bs.pbr.2018.03.007.
  52. Schubert CA-O, Ott M, Hannemann J, Singer M, Bliem HR, Fritzsche K, et al. Dynamic Effects of CAM Techniques on Inflammation and Emotional States: An Integrative Single-Case Study on a Breast Cancer Survivor. Integrative Cancer Therapies. 2021; (1552-695X). Available from: https://doi.org/10.1177%2F1534735420977697.
  53. Su K-P. Are we all the same? The critical role of translational brain, behavior, and immunity research in East Asia. Brain, Behavior, and Immunity. 2019 2019/11/01/; 82:[1-2 pp.]. Available from: https://doi.org/10.1016/j.bbi.2019.07.011.
  54. Ross CL. Energy Medicine: Current Status and Future Perspectives. Global Advances In Health and Medicine. 2019; (2164-957X). Available from: https://doi.org/10.1177%2F2164956119831221.
  55. Torkamani F, Aghayousefi A, Alipour A, Nami M. Effects of Single‐Session Group Mantra‐meditation on Salivary Immunoglobulin A and Affective State: A Psychoneuroimmunology Viewpoint. The Journal of Science and Healing. 2018; 14:[114–21 pp.]. Available from: https://doi.org/10.1016/j.explore.2017.10.010.
  56. Satsangi AK, Brugnoli MP. Anxiety and psychosomatic symptoms in palliative care: from neuro-psychobiological response to stress, to symptoms' management with clinical hypnosis and meditative states. Annals of Palliative Medicine. 2018; (2224-5839). Available from: https://doi.org/10.21037/apm.2017.07.01.
  57. Househam Am Fau - Peterson CT, Peterson Ct Fau - Mills PJ, Mills Pj Fau - Chopra D, Chopra D. The Effects of Stress and Meditation on the Immune System, Human Microbiota, and Epigenetics. Advances in mind-body Medicine. 2017; (1532-1843).
  58. Marvasti FF. 165The Role of Complementary and Alternative Medicine in Integrative Preventive Medicine. Integrative Preventive Medicine. 2017:[0 p.]. Available from: https://doi.org/10.1093/med/9780190241254.003.0009.
  59. Martinec R. Aromatherapy as a complementary method in therapy and rehabilitation. Hrvatska Revija Za Rehabilitacijska Istrazivanja. 2013 06/01; 49:[181-93 pp.].
  60. Yamamoto K, Nagata S. Physiological and psychological evaluation of the wrapped warm footbath as a complementary nursing therapy to induce relaxation in hospitalized patients with incurable cancer: a pilot study. Cancer Nursing. 2011; (1538-9804). Available from: https://doi.org/10.1097/ncc.0b013e3181fe4d2d.
  61. Mills PJ, Jain S. Biofield therapies and psychoneuroimmunology. Brain, Behavior, and Immunity. 2010; (1090-2139). Available from: https://doi.org/10.1016/j.bbi.2010.07.246.
  62. Coakley AB, Duffy ME. The effect of therapeutic touch on postoperative patients. Journal of Holistic Nursing. 2010; (1552-5724). Available from: https://doi.org/10.1177/0898010110368861.
  63. Denner S. The Science of Energy Therapies and Contemplative Practice A Conceptual Review and the Application of Zero Balancing. Holistic nursing practice. 2009 11/01; 23:[315-34 pp.]. Available from: http://dx.doi.org/10.1097/HNP.0b013e3181bf3784.
  64. Uebaba K, Xu F-H, Ogawa H, Tatsuse T, Wang B-H, Hisajima T, et al. Psychoneuroimmunologic Effects of Ayurvedic Oil-Dripping Treatment. Journal of alternative and complementary medicine (New York, NY). 2008 12/01; 14:[1189-98 pp.]. Available from: http://dx.doi.org/10.1089/acm.2008.0273.
  65. Hughes D, Ladas E, Rooney D, Kelly K. Massage Therapy as a Supportive Care Intervention for Children With Cancer. Oncology nursing forum. 2008 06/01; 35:[431-42 pp.]. Available from: http://dx.doi.org/10.1188/08.ONF.431-442.
  66. Walling A. Therapeutic modulation of the psychoneuroimmune system by medical acupuncture creates enhanced feelings of well-being. Journal of the American Academy of Nurse Practitioners. 2006 05/01; 18:[135-43 pp.]. Available from: http://dx.doi.org/10.1111/j.1745-7599.2006.00115.x.
  67. Southam M. Therapeutic Humor: Attitudes and Actions by Occupational Therapists in Adult Physical Disabilities Settings. Occupational therapy in health care. 2003 01/01; 17:[23-41 pp.]. Available from: http://dx.doi.org/10.1080/J003v17n01_03.
  68. Bennett M, Zeller J, Rosenberg L, McCann J. The effect of mirthful laughter on stress and natural killer cell activity. Alternative therapies in health and medicine. 2002 11/30; 9:[38-45 pp.].
  69. Lovas JM, Craig AR, Segal YD, Raison RL, Weston KM, Markus MR. The effects of massage therapy on the human immune response in healthy adults. Journal of Bodywork and Movement Therapies. 2002 2002/07/01/; 6(3):[143-50 pp.]. Available from: https://doi.org/10.1054/jbmt.2001.0251.
  70. Farrar J. Addressing Spirituality and Religious Life in Occupational Therapy Practice. Physical & Occupational Therapy In Geriatrics. 2001 07/28; 18:[65-85 pp.]. Available from: http://dx.doi.org/10.1080/J148v18n04_06.
  71. Eliopoulos C. Using complementary and alternative techniques--boosting immunity. Director (Cincinnati, Ohio). 2000; (1551-8418).
  72. Wright SG, Sayre-Adams J. Healing, energy and the complementary therapies. Complementary therapies in nursing & midwifery. 1999.
  73. Starn JR. The path to becoming an energy healer. Nurse Practitioner Forum: Current Topics and Communications. 1998; (1045-5485).
  74. Miller A. Alternative therapies. What are the spiritual roots? Journal of Christian nursing : a quarterly publication of Nurses Christian Fellowship. 1993; (0743-2550). Available from: https://doi.org/10.1097/00005217-199310030-00004.
  75. Hadamitzky M, Lückemann L, Pacheco-López GA-OX, Schedlowski M. Pavlovian Conditioning of Immunological and Neuroendocrine Functions. Physiological Reviews. 2020; (1522-1210). Available from: https://doi.org/10.1152/physrev.00033.2018.
  76. Yang F, Kosten TR. Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology. 2019 2019/10/01; 236(10):[2899-907 pp.]. Available from: https://doi.org/10.1007/s00213-019-5176-9.
  77. Hulett JM, Armer Jm Fau - Leary E, Leary E Fau - Stewart BR, Stewart Br Fau - McDaniel R, McDaniel R Fau - Smith K, Smith K Fau - Millspaugh R, et al. Religiousness, Spirituality, and Salivary Cortisol in Breast Cancer Survivorship: A Pilot Study. Cancer Nursing. 2018; (1538-9804 (Electronic)). Available from: https://doi.org/10.1097/ncc.0000000000000471.
  78. Hulett JM, Armer JM. A Systematic Review of Spiritually Based Interventions and Psychoneuroimmunological Outcomes in Breast Cancer Survivorship. Integrative Cancer Therapies. 2016; (1552-695X). Available from: https://doi.org/10.1177/1534735416636222.
  79. Bormann JE, Aschbacher K Fau - Wetherell JL, Wetherell Jl Fau - Roesch S, Roesch S Fau - Redwine L, Redwine L. Effects of faith/assurance on cortisol levels are enhanced by a spiritual mantram intervention in adults with HIV: a randomized trial. Journal of Psychosomatic Research. 2009; (0022-3999). Available from: https://doi.org/10.1016/j.jpsychores.2008.09.017.
  80. Payne D. A structured psychiatric intervention for patients with malignant melanoma: Fawzy et al. (1990b). Advances in Mind-Body Medicine. 2001; (1470-3556).
  81. Estevao C. The role of yoga in inflammatory markers. Brain, Behavior, & Immunity - Health. 2022 2022/03/01/; 20. Available from: https://doi.org/10.1016/j.bbih.2022.100421.
  82. Tenfelde S, Janusek LW. Yoga: a biobehavioral approach to reduce symptom distress in women with urge urinary incontinence. Journal of Alternative and Complementary Medicine. 2014; (1557-7708). Available from: https://doi.org/10.1089/acm.2013.0308.
  83. Kiecolt-Glaser JK, Christian L Fau - Preston H, Preston H Fau - Houts CR, Houts Cr Fau - Malarkey WB, Malarkey Wb Fau - Emery CF, Emery Cf Fau - Glaser R, et al. Stress, inflammation, and yoga practice. Psychosomatic Medicine. 2010; (1534-7796). Available from: https://doi.org/10.1097/psy.0b013e3181cb9377.
  84. Ditmer M, Gabryelska A, Turkiewicz S, Białasiewicz P, Małecka-Wojciesko E, Sochal M. Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review. Journal of Clinical Medicine. 2022; 11(1):[67 p.]. Available from: https://doi.org/10.3390/jcm11010067.
  85. Posadzki P, Parekh S, O'Driscoll L, Mucha D. Qi Gong's relationship to educational kinesiology: A qualitative approach. Journal of bodywork and movement therapies. 2010 01/31; 14:[73-9 pp.]. Available from: http://dx.doi.org/10.1016/j.jbmt.2008.11.002.
  86. Mehta A, Kumar Ratre Y, Sharma K, Soni VK, Tiwari AK, Singh RP, et al. Interplay of Nutrition and Psychoneuroendocrineimmune Modulation: Relevance for COVID-19 in BRICS Nations. Frontiers in Microbiology. 2021; 12. Available from: https://doi.org/10.3389/fmicb.2021.769884.
  87. Gostner JM, Geisler S, Stonig M, Mair L, Sperner-Unterweger B, Fuchs D. Tryptophan Metabolism and Related Pathways in Psychoneuroimmunology: The Impact of Nutrition and Lifestyle. Neuropsychobiology. 2020; (1423-0224). Available from: https://doi.org/10.1159/000496293.
  88. Toups M. Inflammation and Depression: the Neuroimmune Connection. Curr Treat Options Psychiatry. 2018 Available from: https://doi.org/10.1007%2Fs40501-018-0157-x.
  89. Melnikov M, Pashenkov M, Boyko A. Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential? International Journal of Molecular Sciences. 2021; 22(10). Available from: https://doi.org/10.3390/ijms22105313.
  90. Prakash Nargatti, Sudhir Patil, Sandip Patil, Naikwade N. Chemopreventive potential of adrenergic blocker in behavioral stress accelerated prostate cancer development in rats. Research Journal of Pharmacy and Technology. 2021; 14:[787-92 pp.]. Available from: http://dx.doi.org/10.5958/0974-360X.2021.00137.2.
  91. Mravec B, Tibensky M, Horvathova L. Stress and cancer. Part II: Therapeutic implications for oncology. Journal of Neuroimmunology. 2020; (1872-8421). Available from: https://doi.org/10.1016/j.jneuroim.2020.577312.
  92. Müller N. A Brief History of Immunological Research into Psychosis and Pathways for Immune Influence of the Brain. Current topics in behavioral Neurosciences. 2020; (1866-3370). Available from: https://doi.org/10.1007/7854_2018_82.
  93. Abdoli AA-O, Mirzaian Ardakani H. Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders. Metabolic Brain Disease. 2020; (1573-7365). Available from: https://doi.org/10.1007/s11011-019-00466-5.
  94. Szałach Ł P, Lisowska KA, Cubała WJ. The Influence of Antidepressants on the Immune System. Archivum Immunologiae et Therapiae Experimentalis. 2019; (1661-4917). Available from: https://doi.org/10.1007/s00005-019-00543-8.
  95. Köhler-Forsberg OA-O, C NL, Hjorthøj CA-O, Nordentoft M, Mors O, Benros ME. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatrica Scandinavica. 2019; (1600-0447). Available from: https://doi.org/10.1111/acps.13016.
  96. Müller N. COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders. Frontiers in Psychiatry. 2019; (1664-0640). Available from: https://doi.org/10.3389%2Ffpsyt.2019.00375.
  97. Jeon SW, Kim YK. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. Journal of Inflammation Research. 2018; (1178-7031). Available from: https://doi.org/10.2147%2FJIR.S141033.
  98. Pfau ML, Ménard C, Russo SJ. Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities. Annual Review of Pharmacology and Toxicology. 2018; (1545-4304). Available from: https://doi.org/10.1146/annurev-pharmtox-010617-052823.
  99. Rubesa G, Gudelj L Fau - Makovac D, Makovac D. Immunological Characteristics of Schizophrenia. Psychiatria Danubina. 2018; (0353-5053).
  100. Toljan K, Vrooman B. Psychoneuroimmunological approach to gastrointestinal related pain. Scandinavian Journal of Pain. 2017; (1877-8879). Available from: https://doi.org/10.1016/j.sjpain.2017.10.010.
  101. Tavakolpour S, Daneshpazhooh M, Mahmoudi H. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care. Cancer Genetics and Psychotherapy. 2017 2017//:[851-934 pp.]. Available from: https://doi.org/10.1007/978-3-319-64550-6_18.
  102. Vetlugina TP, Lobacheva OA, Sergeeva SA, Nikitina VB, Nevidimova TI, Semke AV. Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia. Acta Neuropsychiatrica. 2016; (1601-5215). Available from: https://doi.org/10.1017/neu.2015.60.
  103. Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Frontiers in Neuroscience. 2015; (1662-4548). Available from: https://doi.org/10.3389%2Ffnins.2015.00372.
  104. Iaffaldano P, Ruggieri M Fau - Viterbo RG, Viterbo Rg Fau - Mastrapasqua M, Mastrapasqua M Fau - Trojano M, Trojano M. The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis. Brain, Behavior, and Immunity. 2014; (1090-2139). Available from: https://doi.org/10.1016/j.bbi.2013.08.009.
  105. Debnath M, Venkatasubramanian G. Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics. Current Opinion in Psychiatry. 2013; (1473-6578). Available from: https://doi.org/10.1097/yco.0b013e328363b4da.
  106. Loftis JM, Huckans M. Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy. Pharmacology and Therapeutics. 2013; (1879-016X). Available from: https://doi.org/10.1016%2Fj.pharmthera.2013.04.011.
  107. Rolland B, Deguil J Fau - Jardri R, Jardri R Fau - Cottencin O, Cottencin O Fau - Thomas P, Thomas P Fau - Bordet R, Bordet R. Therapeutic prospects of PPARs in psychiatric disorders: a comprehensive review. Current drug targets. 2013; (1873-5592). Available from: https://doi.org/10.2174/1389450111314070002.
  108. Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ. Anti-inflammatory treatment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 42(1738-1088). Available from: https://doi.org/10.9758%2Fcpn.2020.18.1.10.
  109. Peters E, Sabat R, Philipp S, Helleiner E, Kruse J, Sterry W. Neuroimmunological links in dermatology: Psoriasis as a model disease in stress research. Expert Review of Dermatology. 2014 01/10; 7. Available from: http://dx.doi.org/10.1586/edm.12.36.
  110. Müller N, Myint Am Fau - Schwarz MJ, Schwarz MJ. Immunological treatment options for schizophrenia. Current Pharmaceutical Biotechnology. 2012; (1873-4316). Available from: https://doi.org/10.2174/138920112800784826.
  111. Antonioli M, Rybka J Fau - Carvalho LA, Carvalho LA. Neuroimmune endocrine effects of antidepressants. Neuropsychiatric Disease and Treatment. 2012; (1178-2021). Available from: https://doi.org/10.2147/ndt.s16409.
  112. Buehler MR. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Medical Hypotheses. 2011; (1532-2777). Available from: https://doi.org/10.1016/j.mehy.2011.02.038.
  113. Müller N, Myint Am Fau - Schwarz MJ, Schwarz MJ. Inflammatory biomarkers and depression. Neurotoxicity Research. 2011; (1476-3524). Available from: https://doi.org/10.1007/s12640-010-9210-2.
  114. Müller N, Myint Am Fau - Schwarz MJ, Schwarz MJ. Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. Current Pharmaceutical Design. 2011; (1873-4286). Available from: https://doi.org/10.2174/138161211795049552.
  115. Chaves C, Cristiane R, Wichert-Ana L, Maia-de-Oliveira J, Itikawa E, Crippa J, et al. Minocycline and psychoneuroimmunology in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. 2010 05/01; 34. Available from: http://dx.doi.org/10.1016/j.pnpbp.2010.04.022.
  116. Müller N. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Current Opinion in Investigational Drugs. 2010; (2040-3429).
  117. Müller N, Schwarz M. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: Schizophrenia and major depression as inflammatory CNS disorders. European archives of psychiatry and clinical neuroscience. 2008 07/01; 258 Suppl 2:[97-106 pp.]. Available from: http://dx.doi.org/10.1007/s00406-008-2012-3.
  118. Kendall-Tackett K. A new paradigm for depression in new mothers: The central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health. International breastfeeding journal. 2007 03/30; 2:[6 p.]. Available from: http://dx.doi.org/10.1186/1746-4358-2-6.
  119. Lissoni P, Bolis S Fau - Brivio F, Brivio F Fau - Fumagalli L, Fumagalli L. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies. Anticancer Research. 2000; (0250-7005).
  120. Lissoni P, Laudon M. Immunotherapy with IL02, IL-12 and melatonin as the end-objective of the clinical application of psychoneuroimmune knowledge to the treatment of human neoplasms. International Journal of Thymology. 1998.
  121. Jenkins RH, Hughes STO, Figueras AC, Jones SA. Unravelling the broader complexity of IL-6 involvement in health and disease. Cytokine. 2021 2021/12/01/; 148:[155684 p.]. Available from: https://doi.org/10.1016/j.cyto.2021.155684.
  122. Lewitus GM, Wilf-Yarkoni A Fau - Ziv Y, Ziv Y Fau - Shabat-Simon M, Shabat-Simon M Fau - Gersner R, Gersner R Fau - Zangen A, Zangen A Fau - Schwartz M, et al. Vaccination as a novel approach for treating depressive behavior. Biol Psychiatry. 2009; (1873-2402). Available from: https://doi.org/10.1016/j.biopsych.2008.07.014.
  123. Müller N, Schwarz M, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular psychiatry. 2006 08/01; 11:[680-4 pp.]. Available from: http://dx.doi.org/10.1038/sj.mp.4001805.
  124. Yang EV, Eubank TD. The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer. Cancer Biomarkers. 2013; (1875-8592). Available from: https://doi.org/10.3233/cbm-130325.
  125. McCain NL, Gray Dp Fau - Elswick RK, Elswick Rk Fau - Robins JW, Robins Jw Fau - Tuck I, Tuck I Fau - Walter JM, Walter Jm Fau - Rausch SM, et al. A randomized clinical trial of alternative stress management interventions in persons with HIV infection. Journal of Consulting and Clinical Psychology. 2008; (0022-006X). Available from: https://doi.org/10.1037/0022-006x.76.3.431.
  126. Nwosu I, Khan AA. Management of migraine headache with hyperbaric oxygen: A research review. Biomedical Research. 2007 05/01; 18:[65-82 pp.].
  127. Rutkofsky IH, Khan AS, Sahito S, Kumar V. The Psychoneuroimmunological Role of Omega-3 Polyunsaturated Fatty Acids in Major Depressive Disorder and Bipolar Disorder. Advances in mind-body medicine. 2017; 31 3:[8-16 pp.].
  128. Su KP. Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression. BioMedicine. 2015; (2211-8020). Available from: https://doi.org/10.7603%2Fs40681-015-0021-x.
  129. Su KP. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? NeuroSignals. 2009; (1424-8638). Available from: https://doi.org/10.1159/000198167.
  130. Tanyi RA, Berk Ls Fau - Lee JW, Lee Jw Fau - Boyd K, Boyd K Fau - Arechiga A, Arechiga A. The effects of a psychoneuroimmunology (PNI) based lifestyle intervention in modifying the progression of depression in clinically depressed adults. International Journal of Psychiatry in Medicine. 2011; (0091-2174). Available from: https://doi.org/10.2190/pm.42.2.d.
  131. Lutgendorf SK, Mullen-Houser E Fau - Russell D, Russell D Fau - Degeest K, Degeest K Fau - Jacobson G, Jacobson G Fau - Hart L, Hart L Fau - Bender D, et al. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach. Brain, Behavior, and Immunity. 2010; (1090-2139). Available from: https://doi.org/10.1016/j.bbi.2010.06.014.
  132. Lekander M, Fürst Cj Fau - Rotstein S, Rotstein S Fau - Hursti TJ, Hursti Tj Fau - Fredrikson M, Fredrikson M. Immune effects of relaxation during chemotherapy for ovarian cancer. Psychotherapy and Psychosomatics. 1997; (0033-3190). Available from: https://doi.org/10.1159/000289133.
  133. Yan Q. The role of psychoneuroimmunology in personalized and systems medicine. Methods in Molecular Biology. 2012; (1940-6029). Available from: https://doi.org/10.1007/978-1-62703-071-7_1.
  134. Buckley J. Holism and a health-promoting approach to palliative care. International journal of palliative nursing. 2002 11/01; 8:[505-8 pp.]. Available from: http://dx.doi.org/10.12968/ijpn.2002.8.10.10697.
  135. Bar B. The effect of holism on the health care system. Hospital Materiel Management Quarterly. 1998; (0192-2262).
  136. Ward B. Holistic medicine. Australian family Physician. 1995.
  137. Ley C, Barrio MR. A narrative review of research on the effects of physical activity on people living with HIV and opportunities for health promotion in disadvantaged settings. African Journal of AIDS Research. 2012; (1608-5906). Available from: https://doi.org/10.2989/16085906.2012.698079.
  138. Weisberg MB. 50 years of hypnosis in medicine and clinical health psychology: a synthesis of cultural crosscurrents. American Journal of Clinical Hypnosis. 2008; (0002-9157). Available from: https://doi.org/10.1080/00029157.2008.10401639.
  139. Hall H. Healing mysteries: An interview with Howard Hall, PhD, PsyD. Interview by Sheldon Lewis. Advances in mind-body medicine. 2007 06/01; 22:[28-31 pp.].
  140. Neumann P. The use of hypnosis in modifying immune system response. Australian Journal of Clinical and Experimental Hypnosis. 2005 11/01; 33:[140-59 pp.].
  141. Walker L. Hypnotherapeutic insights and interventions: A cancer odyssey. Contemporary Hypnosis. 2004 03/01; 21:[35-45 pp.]. Available from: http://dx.doi.org/10.1002/ch.286.
  142. Horton-Hausknecht JR, Mitzdorf U Fau - Melchart D, Melchart D. The effect of hypnosis therapy on the symptoms and disease activity in Rheumatoid Arthritis. Psychology and Health. 2000; (0887-0446). Available from: https://doi.org/10.1080/08870440008407369.
  143. Noll R. Hypnotherapy of a Child with Warts. Journal of developmental and behavioral pediatrics : JDBP. 1994 05/01; 9:[89-91 pp.]. Available from: http://dx.doi.org/10.1097/00004703-198804000-00008.
  144. LaBaw W. The use of hypnosis with hemophilia. Psychiatric medicine. 1992; (0732-0868).
  145. Bocci VV. Ozontherapy as a Possible Biological Response Modifier in Cancer. Forschende Komplementarmedizin und Klassische Naturheilkunde. 1998; (1021-7096).
  146. Garza-Reyes JA. Lean and green – a systematic review of the state of the art literature. Journal of Cleaner Production. 2015;102:18-29.

How to Cite

Arman Yurisaldi Saleh, & Miky Endro Santoso. (2022). Research map in the field of psychoneuroimmunology therapy, a bibliometric analysis. Bali Medical Journal, 12(1), 11–43. https://doi.org/10.15562/bmj.v12i1.3603
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Arman Yurisaldi Saleh
Google Scholar
Pubmed
BMJ Journal

Miky Endro Santoso
Google Scholar
Pubmed
BMJ Journal